Clinical Trials Logo

Clinical Trial Summary

This is a prospective, open, non-controlled clinical investigation to evaluate the performance and safety of using Mepilex Transfer Ag on a malignant wound. Approximately ten to fifteen (10-15) subjects from one to three centers in Europe, presenting with a malignant (fungating) wound will be enrolled into the study. Eligible subjects will have one malignant (fungating) wound selected as a "study site". Subjects will be followed for a one-week observation period with their existing product followed by a 4-week investigation period using Mepilex Transfer Ag.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02431741
Study type Interventional
Source Molnlycke Health Care AB
Contact
Status Completed
Phase N/A
Start date October 2014
Completion date December 2015

See also
  Status Clinical Trial Phase
Completed NCT00435474 - Malignant Wounds, Wound Treatment, Psycho-Social Support and Relaxation Therapy Phase 3